Effect of prostaglandin E1 on renal haemodynamics in a patient with diabetic nephropathy

J Int Med Res. 1991 Nov-Dec;19(6):497-500. doi: 10.1177/030006059101900611.

Abstract

A 66-year old male with severe hyperglycaemia due to previously uncontrolled diabetes mellitus was also suffering from arteriosclerosis obliterans and diabetic nephropathy. The patient was treated with 16 IU/day insulin zinc suspension. In addition, an intravenous infusion of 80 micrograms/day prostaglandin E1 was given for 28 days in an attempt to improve the arteriosclerosis obliterans and diabetic nephropathy. Treatment resulted in a reduction in fasting blood glucose but no decline in urinary protein. Prostaglandin E1 treatment, however, produced an improvement in renal haemodynamics assessed by renography.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alprostadil / pharmacology*
  • Arteriosclerosis Obliterans / complications
  • Arteriosclerosis Obliterans / drug therapy*
  • Arteriosclerosis Obliterans / physiopathology
  • Blood Glucose / metabolism
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / physiopathology
  • Hemodynamics / drug effects
  • Humans
  • Infusions, Intravenous
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Male
  • Proteinuria / metabolism

Substances

  • Blood Glucose
  • Alprostadil